Tirzepatide
Proper Handling
- Reconstitute with Bacteriostatic Water
- Specifications: Lyophilized powder. Purity (>99%) meets or exceeds U.S. Pharmacopeia (USP) regulations.
- Storage: In lyophilized form, the peptide is stable for 3 years. Protect from light. Refrigerate and use within 4-6 weeks after opening or reconstituting.
Questions?
Schedule a consultation with a practitioner specialized in peptide therapy, who will determine the best plan for you.
Compounded drugs, medications, and peptides for clinical research are not FDA-approved. Soma has ensured quality, safety and efficacy by performing RP-HPLC, MS, sterility and additional testing that meets or exceeds U.S. Pharmacopeia (USP) and National Formulary (USP-NF) regulations. All peptides are third-party tested with a Certificate of Analysis (COA) that is publicly available. Third party testing verifies that the product complies with the mandates of all relevant regulatory agencies.
CAS Number 2023788-19-2
PubChem CID 2023788-19-2
Molecular Weight 4813.527 g/mol
Molecular Formula C225H348N48O68
Synonyms Mounjaro®, Zepbound™, GTPL11429, P1206, LY3298176
Storage (Lyophilized)
At 39 Fahrenheit: 2 years
At -4 Fahrenheit: 3 years
is sold as a pure compound for research purposes only, unless prescribed by a licensed physician. This product comes in the form of lyophilized powder and must be reconstituted with bacteriostatic water prior to use. Please refer to our terms and conditions prior to purchase.
Safety Information: Keep this product out of the reach of children. This material has limited research available about it and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement, but a pure substance, sold as a raw material. We attest exclusively to the quality, purity and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material. You agree to indemnify us for any adverse effects that may arise from improper handling and/or consumption of this product.
The articles and information on products that may be found on this website are provided exclusively for the purposes of providing information and education. These items are not pharmaceuticals or medications, and the Food and Drug Administration has not given permission for the treatment or prevention of any disease, medical condition, or ailment using them.
Frequently Asked Questions
Tirzepatide
-
Tirzepatide is a unique dual RA of both the GLP-1 and GIP receptors, which significantly reduces HbA1c levels and body weight in patients with T2DM and obesity. Its once-weekly dosing and potential cardiovascular benefits make Tirzepatide an attractive option for treating these conditions.
Studies show that Tirzepatide reduces appetite, improves control of eating, and reduces food cravings in addition to improving glycemic control.
-
The most common side effects of Tirzepatide:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach (abdominal) pain
- Indigestion
- Injection site reactions
- Feeling tired
- Belching
Talk to your healthcare provider about any side effect that bothers you or doesn’t go away. Tell your doctor if you have any side effects.
Remember, everyone reacts differently to substances like Tirzepatide due to individual physiological differences such as metabolism rate and overall health status.
-
Tirzepatide is an injectable peptide administered subcutaneously through the fat. The most fatty parts of the body are the abdomen, side or back of upper arms, and front of thighs.
Tirzepatide is for research purposes only, unless prescribed by a licensed physician.
-
Based on the results of the SURMOUNT trial, Tirzepatide will likely be the most effective obesity medication. The published SURMOUNT trial established the efficacy of Tirzepatide. In this phase 3, controlled study, 2,539 people were randomized to receive either Tirzepatide (at 5, 10 or 15 mg) or a placebo. After 72 weeks of treatment, the following results were observed:
- With the placebo, average weight loss was 3.1%
- With 5 mg Tirzepatide, average weight loss was 15%
- With 10 mg Tirzepatide, average weight loss increased to 19%
- At 15 mg, average weight loss was 20.9% (Semaglutide, the previous weight loss leader, has an average weight loss of 15%)
-
Lyophilized powder is a freeze-dried powder. The shelf life of peptide solutions (commonly cold shipped) is far less than that of lyophilized peptides, and peptides stored in solution are also vulnerable to bacterial degradation.
When storing lyophilized peptides for months or even years, freezing is optimal in order to preserve the peptide’s stability. After opening or reconstituting a peptide with Bacteriostatic Water, peptide solutions are generally stable for up to 45 days when refrigerated at 4C (39F).
If you need instructions to reconstitute your peptide, schedule a wellness consultation.
-
We're happy to help answer questions you may have, or refer you to a licensed healthcare professional for medical advice. Email us at care@somapeptides.com or schedule a wellness consultation.
Your body, your journey.
Millions of people want to know how peptide therapy can help achieve achieve optimal health and performance.
Speak with specialists in peptide therapy about reconstituting lyophilized peptides, proper handling and storage, and other questions you may have.